Understanding how anxiety affects substance use in adolescents
Official title: Adverse Adolescent Pathways to Substance Use
Run by University of North Carolina, Chapel Hill · NCT06977178 · Data updated 2026-11-12
This study is trying to see how anxiety affects substance use in kids aged 12-14 by looking at their brain activity and stress responses.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 12 Years to 14 Years |
| Sex | All |
| Enrollment | 180 (estimated) |
| Sponsor | University of North Carolina, Chapel Hill Academic / other |
| Locations | 1 site (Chapel Hill, North Carolina) |
| Status | Recruiting |
| Started | February 20, 2024 |
| Main results expected | June 30, 2029 |
| Study ends | June 30, 2030 |
| Registry record updated | November 3, 2026 |
| Trial ID | NCT06977178 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adolescents aged 12-14 who exhibit symptoms of anxiety and have not engaged in substance use.
✕Probably not a fit
Patients with severe emotional disturbances, psychosis, or those who have used substances more than three times may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the relationship between anxiety symptoms and adverse pathways to substance use in adolescents aged 12-14. It aims to explore how changes in neural connectivity and physiological stress responses during adolescence contribute to this relationship. Participants will undergo neuroimaging, complete questionnaires, and have their physiological responses monitored during a stress-inducing task. The study will recruit 200 youth, focusing on those at high risk for substance use based on specific behavioral and emotional characteristics.
Why it matters
Potential benefit: If successful, this study could lead to better prevention strategies for substance use in adolescents with anxiety.
How similar studies have gone: Other studies have shown promising results in understanding the links between anxiety and substance use, making this approach both relevant and potentially impactful.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male or female * 12-14 years old, * Report symptoms of anxiety * Understand and sign an assent, and parents will sign a permission and a consent document in English * Meets study hearing and vision requirements * Substance use naïve Exclusion Criteria: * Has any foreign metal objects or implants as determined by the safety questionnaires (e.g., bone screws, shunts or body piercing that can't be removed, etc.) * Has been diagnosed with psychosis or a severe emotional disturbance. * Has used alcohol, tobacco, or marijuana more than 3 times. * Is pregnant. Girls who self-report pregnancy may not participate in the stress evaluation or the MRI scan. * Is taking any medications that directly alter cardiovascular function (e.g., propranolol or other beta blockers). * Any current or lifetime treatment with antipsychotic medication. * Has had a head injury that resulted in a loss of consciousness for more than 5 minutes. * Is planning to get non-removable metal braces. * Impaired intellectual functioning (full-scale intelligence quotient \<70). * Past or current history of a clinically significant central nervous system that could confound brain imaging evaluations.
Where it's running
-
The University of North Carolina at Chapel Hill School of Medicine
Chapel Hill, North Carolina, United States Recruiting
Study contacts
- Principal investigator: Aysenil Belger, PhD — University of North Carolina, Chapel Hill
- Study coordinator: Aysenil Belger, PhD
- Email: aysenil.belger@unc.edu
- Phone: (919)-260-9822
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Single-session intervention to change ambiguity aversion
This trial tests whether one brief intervention can change how adults with intolerance of uncertainty and anxiety make ambiguous decisions and how their brains respond.
-
Psilocybin treatment for individuals with various psychiatric symptoms
This study is testing if a single dose of psilocybin can help people with different mental health issues like depression, anxiety, and PTSD feel better and improve their daily functioning.
-
Multi-level school intervention for LGBTQ youth
This study is testing a new program in high schools to see if it helps LGBTQ youth deal with bullying and improve their mental health and school environment.
-
See if preoperative anxiety affects recovery after major digestive cancer surgery
This study tests whether anxiety before surgery is linked to more complications after major digestive cancer operations in French-speaking adults.
-
Mindful Smartphone Use: A Mindfulness-Based Program for Teens with Sleep and Mood Challenges
This study tests Mindwire, a mindfulness-based program, to see if it helps teens with problematic phone use who also have depression or anxiety.
-
Tele-based wellbeing centres for women's mental health in Bangladesh
A randomized trial tests whether tele-counselling for depression and anxiety in Bangladeshi women is as effective as in-person counselling.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.